DNA CHIP FOR DIAGNOSIS OF CORNEAL DYSTROPHY
    1.
    发明申请
    DNA CHIP FOR DIAGNOSIS OF CORNEAL DYSTROPHY 审中-公开
    用于诊断角膜晶状体的DNA芯片

    公开(公告)号:US20090305394A1

    公开(公告)日:2009-12-10

    申请号:US12160965

    申请日:2007-01-18

    IPC分类号: C07H21/04 C12M1/34

    CPC分类号: C12Q1/6883 C12Q2600/156

    摘要: The present invention relates to oligonucleotides for diagnosis of corneal dystrophy. More particularly, the present invention relates to oligonucleotides for detecting mutation of BIGH3 gene for diagnosis or corneal dystrophy including Avellino corneal dystrophy, which must be precisely diagnosed before vision correction surgery, and a DNA chip for diagnosis of corneal dystrophy, which has the oligonucleotides fixed thereon. According to the present invention, conventional microscopic diagnosis of corneal dystrophy can be replaced with a precise genetic method, which prevents a patient with corneal dystrophy from losing eyesight by eyesight correction surgery after erroneous diagnosis.

    摘要翻译: 本发明涉及用于诊断角膜营养不良的寡核苷酸。 更具体地,本发明涉及用于检测用于诊断或角膜营养不良的BIGH3基因的突变的寡核苷酸,其包括在视力矫正手术之前必须精确诊断的Avellino角膜营养不良,以及用于诊断角膜营养不良的DNA芯片,其具有固定的寡核苷酸 上。 根据本发明,可以用精确的遗传方法代替常规的角膜营养不良症的微观诊断,其可以防止角膜营养不良患者在错误诊断后通过视力矫正手术而失去视力。

    Agent for reduction of scar formation by using wound alkalinization
    4.
    发明授权
    Agent for reduction of scar formation by using wound alkalinization 失效
    通过使用伤口碱化来减少瘢痕形成的药剂

    公开(公告)号:US07255883B2

    公开(公告)日:2007-08-14

    申请号:US10312097

    申请日:2001-06-20

    IPC分类号: A01N59/00 A61K33/00

    CPC分类号: A61K33/00

    摘要: The present invention relates to an agent for reducing scar formation, which inhibits the scar formation by injecting sodium bicarbonate to the dermis tissue of the wound with a syringe to directly control pH of the wound site, namely, by alkalinizing the wound to inactivate TGF-β. According to the present invention, the agent for reducing scar formation by controlling the wound healing process can be clinically and immediately applied to the treatment of tylosis scar and keloid, etc., and is effective to the treatment of intractable fibrosis diseases. Also, the invention can be widely applied in many ways as an easy tool which can control the action of TGF-β in a living organism.

    摘要翻译: 本发明涉及一种用于减少瘢痕形成的药剂,其通过用注射器将碳酸氢钠注入伤口的真皮组织来抑制瘢痕形成,以直接控制伤口部位的pH,即通过使伤口碱化以使TGF- 测试版 根据本发明,通过控制伤口愈合过程来减少瘢痕形成的药剂可以临床上立即应用于治疗泰乐菌瘢痕和瘢痕疙瘩等,对于治疗难治性纤维化疾病是有效的。 此外,本发明可以以许多方式广泛应用,作为可以控制活体中TGF-β的作用的简单工具。

    DNA CHIP FOR DETECTION OF STAPHYLOCOCCUS AUREUS
    8.
    发明申请
    DNA CHIP FOR DETECTION OF STAPHYLOCOCCUS AUREUS 审中-公开
    用于检测油菜的DNA芯片

    公开(公告)号:US20100167951A1

    公开(公告)日:2010-07-01

    申请号:US12522392

    申请日:2007-01-08

    IPC分类号: C40B40/06 C07H21/04

    CPC分类号: C12Q1/689 C12Q1/6837

    摘要: The present invention relates to nucleic acid probes specific to Staphylococcus aureus, which is useful for detecting and identifying S. aureus in a biological sample. More particularly, the present invention relates to a DNA chip for detecting and identifying S. aureus, on which nucleic acid probes derived from 23 S rRNA gene of S. aureus are immobilized. The application of the DNA chips according to the present invention allows time-saving and accurate diagnosis of bacterial infection compared with the conventional bacterial culture methods.

    摘要翻译: 本发明涉及对金黄色葡萄球菌特异性的核酸探针,其可用于检测和鉴定生物样品中的金黄色葡萄球菌。 更具体地,本发明涉及用于检测和鉴定金黄色葡萄球菌的DNA芯片,其上固定有金黄色葡萄球菌23S rRNA基因的核酸探针。 与常规细菌培养方法相比,根据本发明的DNA芯片的应用允许节省细菌感染的准确诊断。